Dr. Michael O'Reilly Joins C10 Labs as Chief Medical Advisor

Core Insights - C10 Labs has appointed Dr. Michael O'Reilly as Chief Medical Advisor to enhance its ability to develop AI-driven healthcare ventures [1][2] - The company aims to bridge the gap between AI research and practical healthcare applications, leveraging Dr. O'Reilly's extensive experience in medical technology [3][4] Company Overview - C10 Labs operates as an Applied AI venture studio and fund, focusing on transforming AI research into commercial ventures in healthcare, energy, and industrial systems [4] - The company is based in Cambridge and New York, utilizing its Applied Venture Science methodology to significantly reduce development timelines from 18-24 months to 90-120 days [4] Leadership and Expertise - Dr. O'Reilly brings a wealth of experience, having previously worked at Apple, where he integrated medical-grade sensors into devices used by over one billion people, and at Masimo, contributing to the $50 billion wearable market [3] - His role at C10 Labs will involve identifying scalable technologies that can impact millions of patients, addressing the challenge of translating research into real-world applications [4] Strategic Initiatives - C10 Labs has been selected to lead NYC's AI Nexus program, which supports over 100 AI ventures through 2029, indicating a strong commitment to fostering innovation in the AI healthcare space [2] - The company emphasizes a hands-on approach to building companies, aiming to ensure that groundbreaking research reaches patients effectively [4]